Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Www.biospace.com save search
U.S. FDA Approves Trodelvy® in Pre-treated HR+/HER2- Metastatic Breast Cancer
Published: 2023-02-03 (Crawled : 19:00) - biospace.com/
GILD | $84.51 3.83% 3.69% 13M
|
Health Technology
|
| O: 3.82%
H: 0.0%
C: 0.0%
trodelvy fda breast cancer
BioSpace Layoff Tracker 2023: Eisai, Vyant Bio, Medicago and More Cut Staff
Published: 2023-02-03 (Crawled : 18:00) - biospace.com/
GOOGL | News S | $104.75 -2.78% -2.85% 65M
|
Technology Services
|
| O: -2.78%
H: 0.0%
C: 0.0%
GOOG | News | $105.2 -3.31% -3.42% 37M
|
Technology Services
|
| O: -3.09%
H: 0.0%
C: 0.0%
TXMD M | $5.27 0.38% 0.38% 34K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
Published: 2023-02-03 (Crawled : 18:00) - biospace.com/
BTCY | $0.8055 1.96% 1.92% 200K
|
Manufacturing
|
| O: 8.23%
H: 0.0%
C: 0.0%
conference stroke work association innovation international
Sanofi Admits Defeat for Myasthenia Gravis Candidate, Drops Phase III Trial
Published: 2023-02-03 (Crawled : 16:00) - biospace.com/
SNY | News | $46.02 -2.58% -2.65% 3.5M
|
Health Technology
|
| O: -4.01%
H: 0.0%
C: 0.0%
for trial sanofi
BioSpace Layoff Tracker 2023: Vyant Bio, Medicago, Evelo and More Cut Staff
Published: 2023-02-03 (Crawled : 15:20) - biospace.com/
TXMD M | $5.27 0.38% 0.38% 34K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
GOOGL | News S | $104.75 -2.78% -2.85% 65M
|
Technology Services
|
| O: -2.78%
H: 0.0%
C: 0.0%
GOOG | News | $105.2 -3.31% -3.42% 37M
|
Technology Services
|
| O: -3.09%
H: 0.0%
C: 0.0%
GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer
Published: 2023-02-03 (Crawled : 15:00) - biospace.com/
GENE 2 d | $1.8 78.22% 43.89% 90M
|
Health Technology
|
| O: 69.85%
H: 0.0%
C: 0.0%
risk for test breast cancer
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
BMY A | $74.45 2.31% -0.54% 10M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
conference
Tonix Pharmaceuticals to Participate in BIO CEO & Investor Conference - February 3, 2023
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
TNXP | $1.24 5.09% 4.84% 2.2M
|
Health Technology
|
| O: 6.9%
H: 0.0%
C: 0.0%
pharmaceuticals ceo conference
PaxMedica, Inc. Secures $3.2 Million Growth Capital From Lind Partners
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
PXMD | $3.395 9.52% 8.69% 12M
|
Health Technology
|
| O: 17.42%
H: 0.0%
C: 0.0%
growth
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
MRK | $102.94 -0.5% -0.1% 11M
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: 0.0%
keytruda for plus therapy
Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
TWST | News | $25.3 -18.12% -22.13% 3.3M
|
Health Technology
|
| O: -17.15%
H: 0.0%
C: 0.0%
financial bioscience results
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
MRNA M | $173.27 -1.75% -1.78% 2.8M
|
Health Technology
|
| O: -1.39%
H: 0.0%
C: 0.0%
PSNL | $3.92 28.95% 22.45% 7.8M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
trials vaccine mrna agreement cancer
Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
TENX 2 d | $1.8 -18.55% -22.78% 7.5M
|
Health Technology
|
| O: -22.17%
H: 0.0%
C: 0.0%
offering therapeutics
Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology
Published: 2023-02-03 (Crawled : 14:00) - biospace.com/
BRKR | $72.53 -0.17% -0.17% 460K
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: 0.0%
Ensysce Biosciences, Inc. Announces $3 Million Registered Direct Offering
Published: 2023-02-03 (Crawled : 14:00) - biospace.com/
ENSC A 2 d | $0.715 -8.6% -9.41% 1.5M
|
Health Technology
|
| O: -10.63%
H: 0.0%
C: 0.0%
offering direct
Ambrx Biopharma Strengthens Clinical Leadership with Appointment of Sandra Aung, Ph.D. as Head of Clinical Development
Published: 2023-02-03 (Crawled : 14:00) - biospace.com/
AMAM A | $1.8 -2.7% 3.33% 320K
|
Professional, Scientific, and T...
|
| O: -1.07%
H: 0.0%
C: 0.0%
NKTR | $3.105 3.5% 3.38% 1.5M
|
Health Technology
|
| O: -4.14%
H: 0.0%
C: 0.0%
biopharma
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - February 3, 2023
Published: 2023-02-03 (Crawled : 14:00) - biospace.com/
INSM | $21.61 -0.55% -0.56% 960K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
nasdaq grants
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2023
Published: 2023-02-03 (Crawled : 14:00) - biospace.com/
AVDL | $7.67 0.13% 0.13% 240K
|
Health Technology
|
| O: 4.43%
H: 0.0%
C: 0.0%
awards nasdaq grant
Cigna Reports Strong Fourth Quarter and Full Year 2022 Results, Establishes 2023 Guidance and Increases Dividend
Published: 2023-02-03 (Crawled : 12:20) - biospace.com/
CI | $292.59 -2.97% 0.82% 2.8M
|
Health Services
|
| O: -1.82%
H: 0.0%
C: 0.0%
dividend year
Vyant Bio Commences a Cash Preservation Plan Including a Reduction in Force
Published: 2023-02-03 (Crawled : 12:00) - biospace.com/
VYNT | $0.835 -18.93% -23.35% 550K
|
Health Care and Social Assistan...
|
| O: -4.0%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.